Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 661 of 6351
-
New radiation technique may ease cancer bone pain better than standard therapy
Symptom relief Recruiting nowThis study is being done to answer the following question: Is Stereotactic Body Radiation Therapy or SBRT (a form of radiation therapy which can deliver high doses of radiation to the specific painful area of the body most affected by cancer, while keeping the radiation beams awa…
Phase 3 • Sponsor: Canadian Cancer Trials Group • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Blood test may guide safer chemo for hodgkin lymphoma patients
Disease control Recruiting nowThis phase II trial tests how well personalized reduction of chemotherapy (nivolumab, doxorubicin, vinblastine and dacarbazine) based on circulating tumor deoxyribonucleic acid (ctDNA) evaluation works for treating patients with Hodgkin lymphoma that may have spread from where it…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
New drug cocktail aims to shrink lung tumors without chemo
Disease control Recruiting nowNon small cell lung carcinoma (NSCLC) is the most frequently occurring histologic subtype of lung cancer and is the leading cause of cancer-related deaths worldwide. The purpose of this study is to assess adverse events and change in disease activity when Telisotuzumab Adizutecan…
Phase 1/2 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Fast lung test may help doctors pick the right antibiotic sooner
Disease control Recruiting nowVentilator-associated pneumonia (VAP) remains one of the main nosocomial infections acquired in the intensive care unit (ICU). VAP is pneumonia occurring 48 hours after intubation. Today, bronchoalveolar lavage (BAL) is used for microbiological diagnosis, with bacterial culture a…
Sponsor: CHU de Reims • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug combo hopes to fight tough cancers in kids and young adults
Disease control OngoingThe goal of this interventional study is to determine the strength of cobolimab and dostarlimab that is most tolerated in children and young adults who have advanced solid tumors. This study also aims: (a) to check if it is safe to use cobolimab and dostarlimab combination in chi…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Radiation plus immunotherapy: a one-two punch against advanced melanoma?
Disease control Recruiting nowThe purpose of this research is to evaluate the addition of radiotherapy to the standard immunotherapy drugs that are given to patients with advanced or metastatic melanoma that has spread to other parts of the body. Radiotherapy uses x-rays to target and kill melanoma cells and …
Phase 2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Promising drug cocktail aims to control aggressive breast cancer
Disease control Recruiting nowTriple-negative breast cancer (TNBC) is among the most aggressive and lethal types of breast cancer, and currently available therapies have an unsatisfactory impact on patients' survival. The primary aim of this clinical trial is to evaluate efficacy in terms of Overall Response…
Phase 2 • Sponsor: European Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Tiny heart, tiny device: new hope for premature babies
Disease control OngoingThis multicenter, single arm, prospective, non-randomized study is designed to evaluate the safety and effectiveness of The Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in pre-mature infants over a period of 6 months.
Sponsor: Merit Medical Systems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could beetroot juice help Moms-to-Be with high blood pressure?
Disease control Recruiting nowHigh blood pressure during pregnancy poses significant risks to both the mother and baby. A combination of factors, including advancing maternal age, rising obesity rates, and metabolic health issues, have amplified the prevalence of this condition. While conventional medicines a…
Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Could free diapers and toys boost breastfeeding rates?
Prevention Stopped earlyThe goal of this study is to assess the effectiveness of social transfers on exclusive breastfeeding rates in São Paulo, Brazil. The main research questions are: 1. Are social transfers effective at increasing exclusive breastfeeding rates 2. Are social transfers effective in pr…
Sponsor: Swiss Tropical & Public Health Institute • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
New hope for kids with rare brain cancer: trial combines chemo and radiation
Disease control Recruiting nowThis is an open-label, comprehensive, iterative investigation of evaluating the use of induction chemotherapy, high-dose chemotherapy, and focal radiation therapy in children with newly diagnosed Embryonal Tumor With Multilayered Rosettes (ETMR).
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
A simple breath: could guided breathing calm heart failure symptoms?
Symptom relief OngoingHeart failure is a leading cause of emergency department admissions, with dyspnea and psychological distress being among the most common presenting symptoms. This randomized controlled trial aims to evaluate the effect of nurse-guided diaphragmatic breathing and pursed-lip breath…
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Radioactive drug aims to shrink aggressive prostate tumors before surgery
Disease control Recruiting nowMale adults with a confirmed diagnosis of prostate adenocarcinoma who meet criteria for localized high risk prostate cancer according to the NCCN guidelines and who are eligible for prostatectomy will be invited to participate. Criteria for high-risk prostate cancer include patie…
Phase 2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug aims to plug leaky kidneys in APOL1 disease
Disease control Recruiting nowThe purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease (AMKD) who are homozygotes or compound heterozygotes for APOL1 high-risk genotypes (G1 and G2). The primary hypothesis to be evaluated is that AZ…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a weekly shot stop weight regain? new study hopes so.
Disease control OngoingThis is a study of retatrutide in participants with obesity. The main purpose is to learn more about how retatrutide maintains body weight loss. The study will have two treatment phases: an 80 week lead-in phase in which all participants will take retatrutide dose 1 and a 36 week…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Immunotherapy drug may save eyes from aggressive skin cancer
Disease control OngoingThis phase II trial studies how well pembrolizumab works in treating patients with orbital (eye socket) and/or periorbital (surrounding the eye socket) cutaneous squamous cell cancer (cSCC) that has spread to nearby tissue or lymph nodes (locally advanced) or has come back after …
Phase 2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New combo aims to tame side effects in Tough-to-Treat lymphoma
Disease control Recruiting nowThis Phase II trial evaluates the optimization of the cytokine release syndrome (CRS) profile for glofitamab in combination with gemcitabine and oxaliplatin (Glofit-GemOx) in participants with relapsed or refractory aggressive B-cell Non-Hodgkin's lymphoma. The study utilizes an …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for Hard-to-Treat prostate cancer: enhertu trial launches
Disease control Recruiting nowUse of Enhertu as a Subsequent Line of Therapy in HER2-Positive Metastatic Castration-Resistant Prostate Adenocarcinoma.
Phase 2 • Sponsor: Washington D.C. Veterans Affairs Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a weekly injection calm heart inflammation in sarcoidosis?
Disease control Recruiting nowThe primary objective of this study is to evaluate the effect of rilonacept, added to standard therapy and compared with standard therapy alone, on improvement in myocardial inflammation in subjects with cardiac sarcoidosis after 24 weeks of therapy.
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New malaria vaccine shows promise in first human trial
Vaccine CompletedThis is a first-in-humans randomized, double-blind, placebo-controlled, age de-escalation Phase 1 trial of Plasmodium falciparum (Pf) late liver stage-arresting replication-competent (LARC) sporozoite (SPZ) malaria vaccine (Sanaria® PfSPZ-LARC2 Vaccine) administered to healthy, m…
Phase 1 • Sponsor: Sanaria Inc. • Aim: Vaccine
Last updated Jun 27, 2026 12:07 UTC